Erlotinib Induced Vasculitis
Journal Title: Journal of Medical Science And clinical Research - Year 2015, Vol 3, Issue 1
Abstract
Erlotinib is a tyrosine kinase inhibitor and is approved in lung cancer especially in adenocarcinoma of lung with mutated EGFR. It has got minimal side effects, the most common toxicity being rash. We present a case of life threatening vasculitis caused by the same agent. This is the first case of vasculitis caused by erlotinib in the literature.
Authors and Affiliations
Dr. Ansar Hussain Hakeem
Keywords
Related Articles
- EP ID EP210506
- DOI -
- Views 54
- Downloads 0
A Histopathological Analysis of Medico Legal Autopsy in Cases of Sudden Death
Background: The term autopsy is derived from the greek word autopsies “to see for oneself”derives from autos (one self) and opsis (“eye”). It is a highly specialized surgical procedure that consists of a thorough examina...
Gastrointestinal Stromal Tumors –A case series –Our Experience Over Four Years in A Tertiary Care Medical College Hospital
Background: Gastrointestinal stromal tumors (GIST) are mesenchymal tumors and account for 3% of all gastrointestinal malignancies. They are unpredictable, rare, enigmatic and display aggressive behavior1 . They express t...
Mid-term maternal cardiovascular profile in preterm and term preeclampsia: a prospective analysis
Aims and Objectives: Maternal cardiovascular system is largely affected in the pathogenesis of preeclampsia. In other words, those women who are destined to develop preeclampsia, severe cardio vascular remodeling with ve...
Prevalance of Cognitive Dysfunction in Elderly Patients Attending a Tertiary Care Teaching Hospital in Puducherry
Elderly population are one of the most vulnerable and major age group of individuals in our population. The rising rate of cognitive diseases such as Alzheimer’s disease, senile dementia and other psychiatric ailments am...
Clinical and Epidemiological Profile of Neonatal Sepsis in Referral Care NICU in South Kerala
Introduction: Neonatal sepsis continues to be a major cause for mortality and morbidity in neonates. It is 30 per 1000 live birth in India. The prevalence is more in preterm babies. As more preterm babies are now survivi...